cetylpyridinium has been researched along with Kidney Failure, Chronic in 1 studies
Cetylpyridinium: Cationic bactericidal surfactant used as a topical antiseptic for skin, wounds, mucous membranes, instruments, etc.; and also as a component in mouthwash and lozenges.
Kidney Failure, Chronic: The end-stage of CHRONIC RENAL INSUFFICIENCY. It is characterized by the severe irreversible kidney damage (as measured by the level of PROTEINURIA) and the reduction in GLOMERULAR FILTRATION RATE to less than 15 ml per min (Kidney Foundation: Kidney Disease Outcome Quality Initiative, 2002). These patients generally require HEMODIALYSIS or KIDNEY TRANSPLANTATION.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bower, L | 1 |
| Warren, C | 1 |
| Manley, G | 1 |
1 other study available for cetylpyridinium and Kidney Failure, Chronic
| Article | Year |
|---|---|
Human serum and urine glycosaminoglycans in health and in patients with chronic renal failure.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Cetylpyridinium; Creatinine; Electrophoresis, Cellulose | 1992 |